Hyperlipidemia screening frequency

For patient information click here

Overview
Screening and treatment of lipid disorders in people at high risk for future coronary heart disease (CHD) events has been recommended by the, 'United States Preventive Services Task Force (USPSTF)' especially for patients with known CHD. However, there is lack of consensus in the screening frequency that should be there.

=== United States Preventive Services Task Force (USPSTF) screening frequency for lipid disorders in adults (DONOT EDIT)===

Clinical Considerations


 * The optimal interval for screening is uncertain. On the basis of other guidelines and expert opinion, reasonable options include every 5 years, shorter intervals for people who have lipid levels close to those warranting therapy, and longer intervals for those not at increased risk who have had repeatedly normal lipid levels.